Worth reading
85Important
Scored from 3 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
930
¥ million (decrease in revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationFiscal year ending March 2026, full year7 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥9,907 million-8.5%
Operating profit¥-15 million
Ordinary income¥5,133 million+623.1%
Net income¥9,663 million-43.9%
Selling, general and administrative expenses¥2,778 million
Gross Profit Margin
Rate27.9%
Results for the three months of the current quarter
Fourth quarter of the fiscal year ended March 2026
Net Sales
¥2,505 million
Gross profit
¥789 million
Operating profit
¥121 million
Ordinary income
¥1,633 million
Net income
¥2,767 million
Full-year earnings forecast
Net Sales
¥19,222 million
Operating profit
¥2,131 million
Ordinary income
¥8,300 million
Profit attributable to owners of the parent
¥7,600 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Global Data Intelligence business-24
Entertainment-related business-9
IT-Related Business76
Wellness-30
Other SG&A expenses and related items-29
New initiatives
- Fully launch operations in the OSINT, cryptocurrency and cyber risk fields in addition to Cellebrite products
- Plan to release 6 new titles, including consumer-oriented titles, in the fiscal year ending March 2027
- Fully launch IoT monitoring solutions and AI predictive maintenance solutions
- Promote M&A and business alliances in fields expected to offer strong affinity and synergies
- Acquire the domestic sales rights for products manufactured by MyWaves Technologies
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Shipment volume changes are described, but specific volumes and unit prices are Not disclosedSegment results
Global Data Intelligence business
Net Sales
¥1,293 million+8.2%
Segment profit
¥140 million-14.6%
Entertainment-related business
Net Sales
¥5,477 million-6.6%
Segment profit
¥648 million-1.4%
IT-Related Business
Net Sales
¥3,158 million-16.9%
Segment profit
¥332 million+29.8%
Wellness
Segment profit
¥-30 million
Medium-term management plan targets
Numerical targets are Not disclosed. The materials state that the revenue growth plan for the fiscal year ending March 2027 is based on the medium-term management planAnnual Dividend
Annual dividend per share¥50
End of period¥50
Acquisition of treasury shares
70
Amount unit¥100 million
Number of Shares767,300
Share unitShares
PeriodAugust to October 2025
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Fiscal year ending March 2026, full year |
| Net Sales | ¥9,907 million (YoY -8.5%) |
| Operating profit | ¥-15 million |
| Ordinary income | ¥5,133 million (YoY +623.1%) |
| Net income | ¥9,663 million (YoY -43.9%) |
| Gross Profit Margin | Rate 27.9% / Year-on-year change (points) Not disclosed |
| Selling, general and administrative expenses | ¥2,778 million |
| Results for the three months of the current quarter | Subject Fourth quarter of the fiscal year ended March 2026 / Net Sales ¥2,505 million / Gross profit ¥789 million / Operating profit ¥121 million / Ordinary income ¥1,633 million / Net income ¥2,767 million |
| Full-year earnings forecast | Net Sales ¥19,222 million / Operating profit ¥2,131 million / Ordinary income ¥8,300 million / Profit attributable to owners of the parent ¥7,600 million |
| Segment results | Global Data Intelligence business Net Sales ¥1,293 million (YoY +8.2%) / Segment profit ¥140 million (YoY -14.6%) / Entertainment-related business Net Sales ¥5,477 million (YoY -6.6%) / Segment profit ¥648 million (YoY -1.4%) / IT-Related Business Net Sales ¥3,158 million (YoY -16.9%) / Segment profit ¥332 million (YoY +29.8%) / Wellness Net Sales Not disclosed / Segment profit ¥-30 million |
| Breakdown of Factors Affecting the Change | Global Data Intelligence business -24 / Entertainment-related business -9 / IT-Related Business 76 / Wellness -30 / Other SG&A expenses and related items -29 |
| Unit price and quantity metrics | Shipment volume changes are described, but specific volumes and unit prices are Not disclosed |
| Medium-term management plan targets | Numerical targets are Not disclosed. The materials state that the revenue growth plan for the fiscal year ending March 2027 is based on the medium-term management plan |
| Annual Dividend | Annual dividend per share ¥50 / Interim Not disclosed / End of period ¥50 |
| Acquisition of treasury shares | Amount 70 / Amount unit ¥100 million / Number of Shares 767,300 / Share unit Shares / Period August to October 2025 |
| New initiatives | Fully launch operations in the OSINT, cryptocurrency and cyber risk fields in addition to Cellebrite products, Plan to release 6 new titles, including consumer-oriented titles, in the fiscal year ending March 2027, Fully launch IoT monitoring solutions and AI predictive maintenance solutions, Promote M&A and business alliances in fields expected to offer strong affinity and synergies, Acquire the domestic sales rights for products manufactured by MyWaves Technologies |
Items this document does not state (14)
Operating profit marginProgress against full-year forecastSelf-assessment against the planKey KPIsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsPayout ratioCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue for the fiscal year ended March 2026 declined due mainly to lower shipment volumes of gaming machine components and other products in the entertainment-related business, the completion of demand for the migration from 3G to LTE (4G) in the IT-related business, and delays in the development and market launch of new 5G and edge AI products. Ordinary profit benefited from the recognition of ¥4,969 million in equity-method investment gains related to Cellebrite. Net income declined because the gain on changes in Cellebrite's equity interest decreased by ¥12,832 million year on year.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.